Armed With Donation From Trial Participant's Family, Cognition (Nasdaq: CGTX) Initiates Expanded Access Program For Experimental DLB Drug

Why did the Air India Boeing 787 crash happen? How will Trump's tariff threats impact the dollar? What caused Oracle's stock to hit a record high? Why was Sen. Alex Padilla forcibly removed at DHS press conference? How will JetZero's factory affect North Carolina jobs? Why is Google Cloud experiencing widespread outages? How is Trump's blocking of California's EV mandate affecting the market?

Armed With Donation From Trial Participant's Family, Cognition (Nasdaq: CGTX) Initiates Expanded Access Program For Experimental DLB Drug

benzinga.com/partner/biotech/25/06/45880765/armed-with-donation-from-trial-participants-family-cognition-nasdaq-cgtx-initiates-expanded-acces

Cognition Therapeutics Inc. (NASDAQ:CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders including Dementia with Lewy Bodies (DLB), just received assistance in those efforts in the form of an anonymous philanthropic donation, which the company says will…

This story appeared on benzinga.com, 2025-06-11 12:01:07.